术前金黄色葡萄球菌筛查与去定植降低假体乳房再造手术部位感染
单中心回顾性队列纳入2018至2023年738例患者共1385枚乳房假体,评估术前金黄色葡萄球菌筛查与去定植对12个月手术部位感染(SSI)的影响。筛查率为73.9%,12个月SSI发生率为5.8%(95%CI 4.7-7.2);筛查与感染风险降低独立相关(OR=0.59;95%CI 0.35-0.98;p=0.041),提示鼻筛查后去定植可有效减少假体置入后感染。
要点
- 术前金黄色葡萄球菌筛查与去定植可使假体乳房再造后SSI风险降低约41%(OR=0.59)。
- 12个月SSI发生率为5.8%(95%CI 4.7-7.2),筛查覆盖73.9%的手术。
- 即刻乳房再造感染风险显著高于假体乳房固定或置换术(OR=2.61)。
核心结论
- 术前鼻部金黄色葡萄球菌筛查后去定植可有效降低乳房假体置入后手术部位感染风险。
研究设计与样本
- 单中心回顾性队列研究,纳入2018年5月1日至2023年5月1日期间所有乳房假体置入患者,随访至2024年5月1日。
- 共纳入738例患者(中位年龄47.3岁)和1385枚假体,采用广义估计方程分析假体在患者内的聚集性,多变量分析校正潜在混杂因素。
主要发现
- 术前筛查在73.9%的手术中完成,12个月SSI发生率为5.8%(95%CI 4.7-7.2)。
- 筛查与感染风险降低独立相关(OR=0.59;95%CI 0.35-0.98;p=0.041)。
- 肥胖和再造类型与感染风险显著相关(p<0.001)。
- 与假体乳房固定术或假体置换术相比,即刻乳房再造后感染风险显著增加(OR=2.61;95%CI 1.62-4.22),而延期乳房再造风险无显著差异(OR=0.67;95%CI 0.21-2.15)。
关键数值与推荐
- 术前金黄色葡萄球菌鼻筛查阳性者行去定植。
- 主要终点为12个月内SSI,经临床和微生物学数据集中复核确认。
临床怎么用
- 对拟行乳房假体置入的患者,术前应常规进行金黄色葡萄球菌鼻筛查,阳性者实施去定植以降低SSI风险。
- 对即刻乳房再造、肥胖等高危患者应加强感染预防措施。
局限性
- 单中心回顾性设计可能引入选择偏倚和残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Implant-based breast reconstruction (BR) is widely performed after curative or prophylactic mastectomy. Surgical site infection (SSI) is a frequent and dreaded complication that is known to compromise the outcomes of BR. Nasal carriage of Staphylococcus aureus is a known risk factor for SSI. Preoperative nasal screening followed by decolonisation in case of positive result has been offered at the Oscar Lambret Centre since 2018. In this study, we evaluated the association between the realisation of an S. aureus screening and decolonisation programme on the risk of SSI after breast implant placement. METHODS: This single-centre retrospective cohort study included all patients who underwent breast implant placement between 01/05/2018 and 01/05/2023, with follow-up until 01/05/2024. The primary endpoint was SSI within 12 months, confirmed via centralised review of clinical and microbiological data. Associations were analysed using generalised estimating equations to account for clustering of implants in patients. Multivariable analyses were adjusted for potential confounders. RESULTS: Overall, 738 patients (median age 47.3 years) and 1385 implants were included. Preoperative screening was performed in 73.9% of the procedures. The 12-month SSI incidence was 5.8% (95% confidence interval [CI] 4.7-7.2). Screening was independently associated with reduced infection risk (OR=0.59; 95% CI 0.35-0.98; p=0.041). Obesity and type of reconstruction were significantly associated with infection risk (p<0.001), compared to implant mastopexy procedures or implant changes, the risk appeared to be significantly increased after immediate BR (OR=2.61; 1.62-4.22) contrasting with delayed BR (OR=0.67; 0.21-2.15). CONCLUSION: This study suggests that nasal screening for S. aureus followed by decolonisation is effective in reducing the risk of infection after breast implant placement.
引用
- Régis C, Parsy R, Chindjou E, et al. Reducing surgical site infection in implant-based breast reconstruction: Impact of preoperative Staphylococcus aureus screening and decolonisation. J Plast Reconstr Aesthet Surg. 2026. PMID: 42858551. doi:10.1016/j.bjps.2026.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。